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Pneumonia Caused 
by Shigella sonnei 
in Man Returned 
from India
To the Editor: Shigellosis is a 
cause of infectious dysentery frequent-
ly occurring in developing countries 
yet usually associated with diarrhea in 
travelers from regions where Shigella 
infections are endemic. Shigella spp. 
are usually spread directly from per-
son to person by the fecal–oral route 
or indirectly by fecal contamination of 
food or water with ingestion of feces 
contaminated food or water (1). Aside 
from clinical intestinal manifestations, 
shigellosis causes a wide variety of ex-
traintestinal signs, such as bacteremia 
or neurologic manifestations (2).
Pneumonia is an atypical but po-
tential complication of shigellosis. In 
developing countries, Shigella sonnei 
and S. ﬂ  exneri infections were report-
ed to cause acute pneumonia in mal-
nourished infants and, in these cases, 
were associated with severe prognosis 
and a death rate of 14% (3).
We describe a case of severe 
pneumonia caused by S. sonnei that 
developed in a man from Italy who 
had traveled to India. This is an atypi-
cal case of shigellosis occurring in an 
immunocompetent person, generally 
healthy and without any underlying 
severe predisposing condition.
A 69-year-old white man was ad-
mitted to the emergency unit of the 
Presidio Ospedaliero, Department of 
Infectious Diseases, Treviso, Italy, on 
February 24, 2008, with severe dys-
pnea and a cough producing purulent 
sputum. He had traveled to India and 
had visited urban and rural areas over 
a 15-day period. He returned home 7 
days before hospital admission. Dur-
ing his travel, the patient reported epi-
sodes of vomiting and moderate diar-
rhea without fever. These signs were 
resolved 4 days before his return to 
Italy. Initial examination showed he 
had a temperature of 37°C and an oxy-
gen saturation of 88% in room air. Ar-
terial blood gas levels were pH 7.42, 
partial pressure of oxygen in arterial 
blood 42 mm Hg, and partial pressure 
of carbon dioxide 35 mm Hg. Because 
of his progressive respiratory failure, 
he was transferred to the intensive 
care unit. Relevant laboratory tests 
were performed, and abnormal values 
of erythrocyte sedimentation rate 85 
mm/h, C-reactive protein 105 mg/L, 
hemoglobin 10.2 g/dL, and neutro-
philia were found.
A chest radiograph showed dif-
fuse pneumonia with inﬁ  ltrates.  A 
computed tomography scan of the tho-
rax showed nodular lesions and cavity 
formations. No neurologic or abdomi-
nal abnormalities were found, and 
peristalsis was within normal limits.
Sputum and bronchial alveolar 
lavage (BAL) smears showed gram-
negative microorganisms. Melioidosis 
was suspected because the man had 
traveled to a known melioidosis-en-
demic area. In view of this informa-
tion, blood, sputum, and BAL samples 
were collected, and the patient was 
immediately given empirical antimi-
crobial drug therapy with amoxicillin/
clavulanic acid, plus meropenem and 
norﬂ  oxacin. Given the absence of gas-
trointestinal symptoms and because 
shigellosis was not suspected, stool 
samples were not obtained. Specimens 
were sent to the Istituto Superiore di 
Sanità, Infectious Diseases Depart-
ment for bacteriologic examination. 
Blood cultures were negative; gram-
negative rods were recovered from the 
sputum and BAL smears. The micro-
organisms were identiﬁ  ed as S. sonnei 
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by the API 20E strip (bioMerieux Ital-
ia, Florence, Italy). The bacteria agglu-
tinated in Shigella group D antiserum 
but failed to agglutinate in Shigella 
groups A, B, and C antisera (Becton 
Dickinson Diagnostic Systems Italia, 
Milan, Italy). To further conﬁ  rm bac-
terial identiﬁ  cation, we ampliﬁ  ed the 
full length of 16S rRNA nucleotide 
sequence by using the universal prim-
ers for eubacteria, 16S rRNAs (27f 5′-
GAGAGTTTGATCCTGGCTCAG-3′ 
and 1495r 5′-CTACGGCTACCTTG
TTACGA-3′) and sequenced the 
PCR product. The sequence obtained 
was compared by using the BLAST 
search tool (www.ncbi.n/m.nib.gov/
BLAST), which showed 100% iden-
tity with the 16S rRNA S. sonnei 
strain AU65 sequence GenBank ac-
cession no. EF032687). Antimicrobial 
drug susceptibility of the isolate was 
determined for 26 agents by the disk-
diffusion method in Mueller Hinton 
agar, according to the Clinical and 
Laboratory Standards Institute. The 
isolate was susceptible to amikacin 
30  μg/mL, ceftazidime 30 μg/mL, 
ceftriaxone 30 μg/mL, meropenem 
10 μg/mL, sulﬁ  soxazole 0.25 μg/mL, 
sulfonamides 300 μg/mL, and triple 
sulfa  23.75/1.25 μg/mL; intermedi-
ate to cefotaxime 30 μg/mL, gen-
tamicin 10 μg/mL, kanamycin 30 μg/
mL, and tobramycin 10 μg/mL; and 
resistant to amoxicillin 25 μg/mL, 
amoxicillin/clavulanic acid 20/10 μg/
mL, ampicillin 10 μg/mL, ampicillin-
sulbactam 20 μg/mL, cefoxitin 30 
μg/mL, chloramphenicol 30 μg/mL, 
ciproﬂ  oxacin 5 μg/mL, clarithromy-
cin 15 μg/mL erythromycin 15 μg/
mL, nalidixic acid 30 μg/mL, nor-
ﬂ  oxacin 10 μg/mL, streptomycin 10 
μg/mL, tetracycline 30 μg/mL, and 
trimethoprim 5 μg/mL.
The patient was discharged from 
hospital after 40 days. At follow-up 
6 months later, his general health sta-
tus was good, and a chest radiograph 
showed no abnormalities.
Extraintestinal signs associated 
with S. sonnei infections are generally 
reported as secondary manifestations 
of dysentery. In particular, bacter-
emia is reported as a gastrointestinal 
complication in infants in developing 
countries (4) or in immunocompro-
mised adults (5); pneumonia associ-
ated with S. sonnei is more rare but 
possible and has been described in 
malnourished children (4,6), in human 
immunodeﬁ  ciency virus–infected pa-
tients (7), and in patients with chronic 
diseases (8–10). Generally, in these 
cases, pneumonia is associated with 
bacteremia.
This reported case of severe pneu-
monia related to S. sonnei is unusual 
in a healthy patient with self-limiting 
dysentery whose symptoms and clini-
cal conditions were not suggestive 
of bacteremia. Vomiting and aspira-
tion of mixed mouth ﬂ  ora containing 
Shigella spp. could be a possible cause 
of pneumonia in this patient. How-
ever, the hematogenous route cannot 
be excluded. A potential explanation 
of the severe illness could be that in 
healthy elderly people the immune 
system functions are less vigorous and 
thus more susceptible to infections. 
Nevertheless, the acute episode in this 
patient was effectively treated by a 
combination of meropenem, norﬂ  oxa-
cin, and amoxicillin/clavulanic acid, 
although the bacterium is resistant to 
the latter 2 drugs.
This case report should be of par-
ticular interest for clinicians because it 
describes an atypical case of extraint-
estinal shigellosis and an example of 
misdiagnosis of melioidosis. Clini-
cians should be alert for pneumonia 
associated to Shigella spp. or Burk-
holderia pseudomallei, speciﬁ  cally 
in healthy people who have traveled 
to areas to which these pathogens are 
endemic.
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Imported Human 
Fascioliasis, United 
Kingdom
To the Editor: We initiated en-
hanced surveillance for human fascio-
liasis after a reported increase in live-
stock cases in the United Kingdom. 
From January 1, 2008, through Janu-
ary 31, 2009, 11 human cases were 
conﬁ   rmed by the reference labora-
tory for England and Wales, compared 
with 6 cases during the preceding 10 
years. The Scottish reference labora-
tory detected no human cases during 
the study period.
Fascioliasis was deﬁ   ned as a 
positive Fasciola immunoﬂ  uorescent 
antibody test with a screening titer 
of 1:32 and either compatible clini-
cal or radiologic features consistent 
with the disease. We obtained clinical 
and radiologic information from the 
referring physician. Clinical features 
of both acute and chronic infection 
include fever, upper abdominal pain, 
malaise, eosinophilia, and impaired 
liver function; therefore, distinguish-
ing between the 2 phases can be difﬁ  -
cult. Fifty percent of chronic infection 
is subclinical (1,2). Compatible radio-
logic features are capsular enhance-
ment with contrast, hypodense nodu-
lar areas, and low-density serpiginous 
lesions (2). Our analysis comprised 11 
cases (Table). Two patients were white 
British, both of whom had recently 
traveled to sub-Saharan Africa. Cases 
from the preceding 10 years diagnosed 
in our laboratory were all in persons 
with histories of travel to fascioliasis-
endemic areas. Therefore, these cases 
do not provide ﬁ  rm evidence of indig-
enous zoonotic transmission within 
England and Wales.
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Table. Characteristics of human fascioliasis case-patients during enhanced surveillance, United Kingdom, January 1, 2008–January
31, 2009* 
Case
no.
Age,
y/sex 
Country 
of origin 
Years since 
migration Other travel
Risk
factor
Clinical
features
Eosinophil
count,
x10
9/L) 
Abnormal
liver 
function Hepatic imaging IFAT†
1 45/F Yemen 7 Yemen 
regularly 
Khat
use
Abdominal
pain
8.4 Yes Mixed-density 
liver lesion (CT) 
1:128
2 44/M Somalia 16 Ethiopia
2007
Khat
use
Fever, 
abdominal
pain
3.4 Yes Serpiginous
lesion (MRI) 
1:64
3 34/F Ethiopia 3 S. Africa 
regularly 
Khat
use
Fever, 
abdominal
pain
11.4 No Heterogeneous 
lesion (USS) 
1:128
4 44/F Somalia 7 Somalia
2004,
Netherlands
Khat
use
Abdominal
pain
8.3 No Heterogeneous 
lesion (USS) 
1:128
5 54/F Somalia 21 (to 
Netherlands),
4 (to UK) 
None Khat
use
Anorexia 8.4 No Low-density 
lesion (CT) 
1:32
6 43/M Somalia 28 (to India), 
21 (to UK) 
None Khat
use
Fever 1.0 Yes Heterogeneous 
lesion (USS) 
1:128
7 28/F UK – Uganda
2007–2008
– Abdominal
pain,
hepatomegaly 
1.84 Yes Hepatomegaly 
with large mixed 
cystic and solid 
lesion (USS) 
1:512
8 67/M UK – Kenya 
2008, prior 
world travel 
– Malaise,
abdominal
pain
0.04 Yes Multiple
gallstones
(MRCP)
1:256
9 38/M Ethiopia 10 Ethiopia
2006
– Abdominal
pain, fever 
18.7 Yes Normal  (USS, 
MRCP)
1:128
10 28/M Ethiopia Unknown Unknown – Fever,  gram- 
negative
sepsis; new 
HIV diagnosis 
<0.04 Yes Lesion  in 
hepatic vein 
1:64
11 47/F Somalia 16 (to 
Yemen), 
6 (to UK) 
Unknown  Khat
use
Abdominal
pain, fever 
16.8 Yes Low-density 
lesion (CT) 
1:256
*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic 
resonance cholangiopancreatography.  
†Titer of IFAT (screening titer 32). 